Clinical Pharmacokinetics of Valproic Acid (original) (raw)

• Bardy, A.; Hari, R.; Lehtovaara, R. and Majuri, H.: Valproate may lower serum-phenytoin. Lancet 1297–1298 (1976).
• Barnes, S.E. and Bower, B.D.: Sodium valproate in the treatment of intractable childhood epilepsy. Developmental Medicine and Child Neurology 17: 175–181 (1975).
  Article PubMed CAS Google Scholar
• Baruzzi, A.; Bordo, B.; Bossi, L.; Castelli, D.; Gerna, M.; Tognoni, G. and Zagnoni, P.: Plasma levels of di-n-propyl-acetate and clonazepam in epileptic patients. International Journal of Clinical Pharmacology 15: 403–408 (1977).
  CAS Google Scholar
• Beckner, R.R.: Valproic acid. Drug Intelligence and Clinical Pharmacy 13: 18–21 (1979).
  Google Scholar
• Bowdle, T.A.; Levy, R.H, and Cutler, R.E.: Effect of carbamazepine on valproic acid clearance in normal man. Clinical Pharmacology and Therapeutics 25: 215 (1979).
  Google Scholar
• Brachet-Liermain, A. and Demarquez, J.L.: Pharmacokinetics of dipropyl acetate in infants and young children. Pharmaceutisch Weekblad 112: 293–297 (1977).
  CAS Google Scholar
• Brachet-Liermain, A. and Loiseau, P.: A study of a drug combination: dipropyl acetate and phenobarbital. Pharmaceutisch Weekblad 112: 321–323 (1977).
  Google Scholar
• Bruni, J.; Wilder, B.J.; Willmore, L.J.; Perchalski, R.J. and Villareal, H.J.: Steady-state kinetics of valproic acid in epileptic patients. Clinical Pharmacology and Therapeutics 24: 324–332 (1978).
  PubMed CAS Google Scholar
• Burton, B.S.: On the propyl derivatives and decomposition products of ethyl acetoacetate. American Chemical Journal 3: 385–395 (1881).
  Google Scholar
• Chard, C.R.: A simple method for the determination of Epilim in serum; in Legg (Ed) Clinical and Pharmacological Aspects of Sodium Valproate (Epilim) in the Treatment of Epilepsy; pp. 89–91 (MCS Consultants, Tunbridge Wells 1976).
  Google Scholar
• Ciesieleski, L.; Maitre, M.; Cash, C. and Mandel, P.: Regional distribution and effect on cerebral mitochondrial respiration of the anticonvulsive drug n-dipropylacetate. Biochemical Pharmacology 24: 1055–1059 (1975).
  Article Google Scholar
• Degen, R.: Nebenwirkungen bei antiepileptischer Langzeittherapie. Kinderarzt 6: 1038–1051 (1975).
  Google Scholar
• Espir, M.L.E.; Benton, P.; Will, E.; Hayes, M.J. and Walker, G.: Sodium valproate (Epilim) — some clinical and pharmacological aspects; in Legg (Ed) Clinical and Pharmacological Aspects of Sodium Valproate (Epilim) in the Treatment of Epilepsy, pp. 145–151 (MCS Consultants, Tunbridge Wells 1976).
  Google Scholar
• Eymard, P.; Simiand, J.; Teoule, R.; Polverelli, M.; Werbenec, J.P. and Broil, M.: Etude de la repartition et de la resorption de dipropylacetate de sodium marque au 14C chez le rat. Journal de Pharmacologie 2: 359–368 (1971).
  Google Scholar
• Ferrandez, B. and Eymard, P.: Methode rapide d’analyse quantitative du dipropylacetate de sodium dans le serum ou le plasma. Annales Pharmaceutiques Franses 31: 279–282 (1973).
  Google Scholar
• Ferrandez, B. and Eymard, P.: Metabolism of valproate sodium in rabbit, rat, dog and man. Epilepsia 18: 169–182 (1977).
  Article Google Scholar
• Flachs, H.; Wurtz-Jorgensen, A.; Gram, L. and Wulff, K.: Sodium di-n-propyl acetate — its interaction with other antiepileptic drugs. Pharmaceutisch Weekblad 112: 320 (1977).
  Google Scholar
• Froscher, W.; Schulz, H.-U. and Gugler, R.: Valproinsaure in der Behandlung der Epilepsien unter besonderer Berucksichtigung des Serumspiegels. Fortschritte der Neurologie und Psychiatrie 46: 327–341 (1978).
  CAS Google Scholar
• Gompertz, D.; Tippett, P.; Bartlett, K. and Baillie, T.: Identification of urinary metabolites of sodium dipropylacetate in man: potential sources of interference in organic acid screening procedures. Clinica Chimica Acta 74: 153–160 (1977).
  Article CAS Google Scholar
• Gram, L.; Flachs, H.; Wurtz-Jorgensen, A.; Parnas, J. and Andersen, B.: Sodium valproate, serum level and clinical effect in epilepsy: A controlled study. Epilepsia 20: 303–312 (1979).
  Article PubMed CAS Google Scholar
• Gram, L.; Wulff, K.; Rasmussen, K.E.; Flachs, H.; Wurtz-Jorgensen, A.; Sommerbeck, K.W. and Lohren, V.: Valproate sodium: A controlled clinical trial including monitoring of drug levels. Epilepsia 18: 141–148 (1977).
  Article PubMed CAS Google Scholar
• Gugler, R.: The effect of disease on the response to drugs. Advances in Pharmacology and Therapeutics 6: 67–76 (Pergamon Press, Oxford and New York 1978).
  Google Scholar
• Gugler, R.: Valproic acid kinetics in patients with acute viral hepatitis. In press (1979).
• Gugler, R.: Eichelbaum, M.; Schell, A.; Froscher, W.; Kiefer, H.; Schulz, H.-U. and Muller, G.: The Disposition of Valproic Acid WODADIBOF IV. Raven Press, New York, in press 1979)
  Google Scholar
• Gugler, R. and Muller, G.: Plasma protein binding of valproic acid in healthy subjects and in patients with renal disease. British Journal of Clinical Pharmacology 5: 441–446 (1978).
  Article PubMed CAS Google Scholar
• Gugler, R.; Schell, A.; Eichelbaum, M.; Froscher, W. and Schulz, H.-U.: Disposition of valproic acid in man. European Journal of Clinical Pharmacology 12: 125–132 (1977).
  Article PubMed CAS Google Scholar
• Gugler, R.; Schoeman, D.W.; Huffman, D.H.; Cohlmia, J B. and Azarnoff, D.L.: Pharmacokinetics of drugs in patients with the nephrotic syndrome. Journal of Clinical Investigation 55: 1082–1089 (1975).
  Article Google Scholar
• Haigh, D. and Forsythe, W.I.: The treatment of childhood epilepsy with sodium valproate. Developmental Medicine and Child Neurology 17: 743–748 (1975).
  Article PubMed CAS Google Scholar
• Jakobs, C. and Loscher, W.: Identification of metabolites of valproic acid in serum of humans, dog, rat, and mouse. Epilepsia 19: 591–602 (1978).
  Article PubMed CAS Google Scholar
• Jeavons, P.M. and Clark, J.E.: Sodium valproate in treatment of epilepsy. British Medical Journal 2: 584–586 (1974).
  Article PubMed CAS Google Scholar
• Jeavons, P.M.; Clark, J.E. and Maheshwari, M.C.: The treatment of generalised epilepsies of childhood and adolescence with sodium valproate. Developmental Medicine and Child Neurology 19: 9–25 (1977).
  Article PubMed CAS Google Scholar
• Johannessen, S.I.: Preliminary observations on valproic acid kinetics in patients with epilepsy. Arzneimittel-Forschung 27: 1083–1085 (1977).
  PubMed CAS Google Scholar
• Johannessen, S I. and Hendriksen, O.: Serum levels of di-n-propyl acetate in epileptic patients. Pharmaceutisch Weekblad 112: 287–289 (1977).
  Google Scholar
• Jordan, B.J.; Shillingford, J.S. and Steed, K.P.: Preliminary observations on the protein-binding and enzyme-inducing properties of sodium valproate (Epilim); in Legg (Ed) Clinical and Pharmacological Aspects of Sodium Valproate (Epilim) in the Treatment of Epilepsy, pp. 112–116 (MCS Consultants, Tunbridge Wells 1976).
  Google Scholar
• Klotz, U. and Antonin, K.H.: Pharmacokinetics and bioavailability of sodium valproate. Clinical Pharmacology and Therapeutics 21: 736–743 (1977).
  PubMed CAS Google Scholar
• Klotz, U.; Rapp, T. and Muller, W.A.: Disposition of valproic acid in patients with liver disease. European Journal of Clinical Pharmacology 13: 55–60 (1978).
  Article PubMed CAS Google Scholar
• Kochen, W. and Scheffner, D.: The Investigation of Unsaturated Metabolites of Valproic Acid in Serum of Epileptic Children (WODADIBOF IV. Raven Press, New York, in press 1979).
  Google Scholar
• Kochen, W.; Imbeck, H. and Jakobs, C.: Untersuchungen uber die Ausscheidung von Metaboliten der Valproinsaure im Urin der Ratte und des Menschen. Arzneimittel-Forschung 27: 1090–1099 (1977).
  PubMed CAS Google Scholar
• Kuhara, T.; Hirokata, Y.; Yamada, S. and Matsumoto, I.: Metabolism of sodium dipropylacetate in humans. European Journal of Drug Metabolism and Pharmacokinetics 3: 171–177 (1978).
  Article CAS Google Scholar
• Kuhara, T. and Matsumoto, I.: Metabolism of branched medium chain length fatty acid I — ω-Oxidation of sodium dipropyl-acetate in rats. Biomedical Mass Spectrometry 1: 291–294 (1974).
  Article PubMed CAS Google Scholar
• Kukino, K.; Mineura, K.; Deguchi, T.; Ishli, A. and Takahira, H.: Studies on a new anticonvulsant drug, sodium dipropylacetate. Assay for metabolites and metabolic pathway. Yakugaku Zasshi 92: 896–900 (1972).
  PubMed CAS Google Scholar
• Loscher, W.: Serum protein binding and pharmacokinetics of valproate in man, dog, rat and mouse. Journal of Pharmacology and Experimental Therapeutics 204: 255–261 (1978).
  PubMed CAS Google Scholar
• Loiseau, P.; Brachet, A. and Henry, P.: Concentration of dipropylacetate in plasma. Epilepsia 16: 609–615 (1975).
  Article PubMed CAS Google Scholar
• Matsumoto, I.; Kuhara, T. and Yoshino, M.: The effect of isoleucine on the metabolism of sodium dipropylacetate in rats; in Frigerio and Castagnoli (Eds) Advances in Mass Spectrometry in Biochemistry and Medicine 1: 17–26 (Spectrum Publications, New York 1976).
  Google Scholar
• Matsumoto, I.; Kuhara, T. and Yoshino, M.; Metabolism of branched medium chain length fatty acid II — β-Oxidation of sodium dipropylacetate in rats. Biomedical Mass Spectrometry 3: 235–240 (1976).
  Article PubMed CAS Google Scholar
• Mattson, R.H.; Cramer, J.A.; Williamson, P.D. and Novelly, R.A.; Valproic acid in epilepsy: Clinical and pharmacological effects. Annals of Neurology 3: 20–25 (1978).
  Article PubMed CAS Google Scholar
• Meijer, J.W.A. and Hessing-Brand. L.: Determination of lower fatty acid, particularly the antiepileptic dipropylacetic acid, in biological material by means of microdiffusion and gas chromatography. Clinica Chimica Acta 43: 215–222 (1973).
  Article CAS Google Scholar
• Meijer, J.W.A. and Meinardi, H.: Pharmacokinetic studies on sodium valproate; in Legg (Ed) Clinical and Pharmacological Aspects of Sodium Valproate (Epilim) in the Treatment of Epilepsy, pp. 70–74 (MCS Consultants, Tunbridge Wells 1976).
  Google Scholar
• Meinardi, H.; Hanke, N.F.J. and van Beveren, J.: Sodium di-n-propylacetate: Estimation of effective serum levels. Pharmaceutisch Weekblad 109: 45–47 (1974).
  CAS Google Scholar
• Meinardi, H.; van der Kleijn, E.; Meijer, J.W.A. and van Rees, H.: Absorption and distribution of antiepileptic drugs. Epilepsia 16: 353–365 (1975).
  Article PubMed CAS Google Scholar
• Meunier, H.; Carraz, G.; Meunier, V. and Eymard, M.: Proprietes pharmacodynamiques de l’acide n-propylacetique. Therapie 18: 435–438 (1963).
  PubMed CAS Google Scholar
• Mortel, I. and Franck, G.: Etude pharmacocinetique du di-n-propylacetate de sodium sous les formes ordinaire et retard. Acta Neurologica et Psychiatrica Belgica 76: 165–172 (1976).
  Google Scholar
• Oelkers, W.; Stoffels, G.; Schafer, H. and Reith, H.: Zur enteralen Resorption von Valproinsaure. Arzneimittel-Forschung 27: 1088–1090 (1977).
  PubMed CAS Google Scholar
• Oldigs, H.D.; Bartels, H.; Wallis, S.; Warecka, A. and Grob-Selbeck, G.: The effect of galenics on the blood level fluctuations of dipropylacetate — comparative investigation of small intestine-soluble coated pills and a retard form in children. Epilepsia 20: 182 (1979).
  Google Scholar
• Patel, I.H. and Levy, R.H.: Valproic acid binding to human serum albumin and determination of free fraction in the presence of anticonvulsants and free fatty acids. Epilepsia 20: 85–90 (1979).
  Article PubMed CAS Google Scholar
• Patsalos, P.N. and Lascelles, P.T.: Valproate may lower serum-phenytoin. Lancet 50–51 (1977a).
• Patsalos, P.N. and Lascelles, P.T.: Effect of sodium valproate on plasma protein binding of diphenylhydantoin. Journal of Neurology, Neurosurgery and Psychiatry 40: 570–574 (1977b).
  Article CAS Google Scholar
• Penry, J.K.; Porter, R.J.; Sato, S.; Reddenbough, J. and Drifuss, F.E.: Effect of sodium valproate in generalized spike-wave paroxysms in the electroencephalogram; in Legg (Ed) Clinical and Pharmacological Aspects of Sodium Valproate (Epilim) in the Treatment of Epilepsy, pp. 158–164 (MCS Consultants, Tunbridge Wells 1976).
  Google Scholar
• Perucca, E.; Gatti, G.; Frigo, G.M.; Crema, A.; Calzetti, S. and Visintini, D.: Disposition of sodium valproate in epileptic patients. British Journal of Clinical Pharmacology 5: 495–499 (1978).
  Article PubMed CAS Google Scholar
• Pfaff, M.-C. and Mahuzier, G.: Contribution a l’etude du metabolisme de l’acide dipropylaceutique et du dipropylacetamide. Annales Pharmacetiques Francaises 33: 355–363 (1975).
  CAS Google Scholar
• Pinder, R M.; Brogden, R.N.; Speight, T.M. and Avery, G.S.: Sodium valproate: A review of its pharmacological properties and therapeutic efficacy in epilepsy. Drugs 13: 81–123 (1977).
  Article PubMed CAS Google Scholar
• Portratz, J. and Schulz, H.-U.: Protein binding of dipropylacetate (DPA) in human plasma. Naunyn Schmiedebergs Archives of Pharmacology 294: R9 (1976).
  Article Google Scholar
• Richens, A.; Scoular, I.T.; Ahmed, S. and Jordan, B.J: Pharmacokinetics and efficacy of Epilim in patients receiving long term therapy with other antiepileptic drugs; in Legg (Ed) Clinical and Pharmacological Aspects of Sodium Valproate (Epilim) in the Treatment of Epilepsy, pp. 78–88 (MCS Consultants, Tunbridge Wells 1976).
  Google Scholar
• Schafer, H. and Luhrs, R.: Metabolite pattern of valproic acid. Arzneimittel-Forschung 28: 657–662 (1978).
  PubMed CAS Google Scholar
• Schafer, H.; Luhrs, R. and Reith, H.; Chemistry, pharmacokinetics and biological activity of some metabolites of valproic acid. WODADIBOF IV, Raven Press, New York, in press 1979).
  Google Scholar
• Schafer, J. and Kettner, I.: Erfahrungen mit Dipropylacetat in der Behandlung therapieresistenter erwachsener Anfallskranker. Medizinische Welt 25: 561–563 (1974).
  PubMed CAS Google Scholar
• Schmid, R.D.: Propionic acid and dipropylacetic acid in the urine of patients treated with dipropylacetic acid. Clinica Chimica Acta 74: 39–42 (1977).
  Article CAS Google Scholar
• Schobben, F. and van der Kleijn, E.: Pharmacokinetics of distribution and elimination of sodium di-n-propylacetate in mouse and dog. Pharmaceutisch Weekblad 109: 33–42 (1974).
  CAS Google Scholar
• Schobben, F.; van der Kleijn, E. and Gabreels, F.J.M.: Pharmacokinetics of di-n-propylacetate in epileptic patients. European Journal of Clinical Pharmacology 8: 97–105 (1975).
  Article PubMed CAS Google Scholar
• Schobben, F.; Vree, T.B.; van der Kleijn, E.; Claessens, R. and Renier, W.O.; Metabolism of Valproic Acid (WODADIBOF IV, Raven Press, New York, in press 1979).
  Google Scholar
• Schulz, H.-U.; Froscher, W.; Gugler, R. and Eichelbaum, M.: Untersuchungen zum therapeutischen Bereich der Valproinsaure. Medizinische Welt 30: 59–61 (1979).
  PubMed CAS Google Scholar
• Simon, D. and Penry, J.K.: Sodium di-n-propylacetate (DPA) in the treatment of epilepsy. Epilepsia 16: 549–573 (1975).
  Article PubMed CAS Google Scholar
• Swanson, B.N.; Harland, R.C.; Dickinson, R.G. and Gerber, N.: Excretion of valproic acid into semen of rabbits and man. Epilepsia 19: 541–546 (1978).
  Article PubMed CAS Google Scholar
• Unruh, G.E. von; Jancik, B.Ch. and Hoffmann, F.: Unpublished results.
• Vajda, F.; Morris, P.; Drummer, O. and Bladin, P.: Studies on sodium valproate — a new anticonvulsant; in Legg (Ed) Clinical and Pharmacological Aspects of Sodium Valproate (Epilim) in the Treatment of Epilepsy pp. 92–100 (MCS Consultants, Tunbridge Wells 1976).
  Google Scholar
• Vakil, S.D.; Critchley, E M.R.; Philips, J.C.; Fahim, Y.; Haydock, C.; Cocks, A. and Dyr, T.: The effect of sodium valproate (Epilim) on phenytoin and phenobarbitone blood levels; in Legg (Ed) Clinical and Pharmacological Aspects of Sodium Valproate (Epilim) in the Treatment of Epilepsy pp. 75–77 (MCS Consultants, Tunbridge Wells 1976).
  Google Scholar
• Volzke, E. and Doose, H.: Dipropylacetic acid in the treatment of epilepsy. Epilepsia 14: 185–193 (1973).
  Article PubMed CAS Google Scholar
• Whittle, B.A.: Pre-clinical, teratological studies on sodium valproate and other anticonvulsants; in Legg (Ed) Clinical and Pharmacological Aspects of Sodium Valproate (Epilim) in the Treatment of Epilepsy pp. 105–110 (MCS Consultants, Tunbridge Wells 1976).
  Google Scholar
• Windorfer, A.; Sauer, W. and Gadeke, R.: Elevation of diphenylhydantoin and primidone serum concentrations by addition of dipropylacetate, a new anticonvulsant drag. Acta Paediatrica Scandinavica 64: 771–772 (1975).
  Article PubMed Google Scholar
• Wulff, K.; Flachs, H.; Wurtz-Jorgensen, A. and Gram, L.: Clinical pharmacological aspects of valproate sodium. Epilepsia 18: 149–157 (1977).
  Article PubMed CAS Google Scholar
• Zagoni, P.; Avanzini, G.; Baruzzi, A.; Canger, R.; Gerna, M.; Righetti, A. and Morselli, P.L.: Sodium 2-n-propyl pentanoate plasma concentrations in epileptic patients. Pharmaceutisch Weekblad 112: 300–304 (1977).
  Google Scholar